FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:MTSS1L-DGCR8

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: MTSS1L-DGCR8
FusionPDB ID: 55914
FusionGDB2.0 ID: 55914
HgeneTgene
Gene symbol

MTSS1L

DGCR8

Gene ID

92154

54487

Gene nameMTSS I-BAR domain containing 2DGCR8 microprocessor complex subunit
SynonymsABBA|ABBA-1|ABBA1|MTSS1LC22orf12|DGCRK6|Gy1|pasha
Cytomap

16q22.1

22q11.21

Type of geneprotein-codingprotein-coding
Descriptionprotein MTSS 2MTSS1-like proteinMTSS1L, I-BAR domain containingactin-bundling with BAIAP2 homology protein 1metastasis suppressor 1-likemicroprocessor complex subunit DGCR8DiGeorge syndrome critical region 8DiGeorge syndrome critical region gene 8
Modification date2020031320200320
UniProtAcc.

Q8WYQ5

Main function of 5'-partner protein: FUNCTION: Component of the microprocessor complex that acts as a RNA- and heme-binding protein that is involved in the initial step of microRNA (miRNA) biogenesis. Component of the microprocessor complex that is required to process primary miRNA transcripts (pri-miRNAs) to release precursor miRNA (pre-miRNA) in the nucleus. Within the microprocessor complex, DGCR8 function as a molecular anchor necessary for the recognition of pri-miRNA at dsRNA-ssRNA junction and directs DROSHA to cleave 11 bp away form the junction to release hairpin-shaped pre-miRNAs that are subsequently cut by the cytoplasmic DICER to generate mature miRNAs (PubMed:26027739, PubMed:26748718). The heme-bound DGCR8 dimer binds pri-miRNAs as a cooperative trimer (of dimers) and is active in triggering pri-miRNA cleavage, whereas the heme-free DGCR8 monomer binds pri-miRNAs as a dimer and is much less active. Both double-stranded and single-stranded regions of a pri-miRNA are required for its binding (PubMed:15531877, PubMed:15574589, PubMed:15589161, PubMed:16751099, PubMed:16906129, PubMed:16963499, PubMed:17159994). Specifically recognizes and binds N6-methyladenosine (m6A)-containing pri-miRNAs, a modification required for pri-miRNAs processing (PubMed:25799998). Involved in the silencing of embryonic stem cell self-renewal (By similarity). {ECO:0000250|UniProtKB:Q9EQM6, ECO:0000269|PubMed:15531877, ECO:0000269|PubMed:15574589, ECO:0000269|PubMed:15589161, ECO:0000269|PubMed:16751099, ECO:0000269|PubMed:16906129, ECO:0000269|PubMed:16963499, ECO:0000269|PubMed:17159994, ECO:0000269|PubMed:25799998, ECO:0000269|PubMed:26027739, ECO:0000269|PubMed:26748718}.
Ensembl transtripts involved in fusion geneENST idsENST00000338779, ENST00000351989, 
ENST00000383024, ENST00000407755, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score6 X 7 X 6=2529 X 8 X 6=432
# samples 79
** MAII scorelog2(7/252*10)=-1.84799690655495
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(9/432*10)=-2.26303440583379
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: MTSS1L [Title/Abstract] AND DGCR8 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: MTSS1L [Title/Abstract] AND DGCR8 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)MTSS1L(70719625)-DGCR8(20077498), # samples:1
Anticipated loss of major functional domain due to fusion event.MTSS1L-DGCR8 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MTSS1L-DGCR8 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MTSS1L-DGCR8 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
MTSS1L-DGCR8 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneMTSS1L

GO:0036120

cellular response to platelet-derived growth factor stimulus

20875796

HgeneMTSS1L

GO:0090630

activation of GTPase activity

20875796

TgeneDGCR8

GO:0031053

primary miRNA processing

15531877|15574589|24449907|24910438



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:70719625/chr22:20077498)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across MTSS1L (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across DGCR8 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000338779MTSS1Lchr1670719625-ENST00000351989DGCR8chr2220077498+3406344291642537
ENST00000338779MTSS1Lchr1670719625-ENST00000383024DGCR8chr2220077498+3311344291543504
ENST00000338779MTSS1Lchr1670719625-ENST00000407755DGCR8chr2220077498+3308344291543504

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000338779ENST00000351989MTSS1Lchr1670719625-DGCR8chr2220077498+0.0023713550.9976286
ENST00000338779ENST00000383024MTSS1Lchr1670719625-DGCR8chr2220077498+0.0017432410.99825674
ENST00000338779ENST00000407755MTSS1Lchr1670719625-DGCR8chr2220077498+0.0017664640.99823356

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for MTSS1L-DGCR8

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
MTSS1Lchr1670719625DGCR8chr222007749834437PPEARDPGARRGRPLSAAWRREARPG

Top

Potential FusionNeoAntigen Information of MTSS1L-DGCR8 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MTSS1L-DGCR8_70719625_20077498.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B57:01RGRPLSAAW0.99780.98421019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B58:02RGRPLSAAW0.99580.98191019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B27:04ARRGRPLSA0.99280.7762817
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B58:01RGRPLSAAW0.98580.98181019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B15:17RGRPLSAAW0.96440.95051019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B57:03RGRPLSAAW0.92270.98991019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B14:02ARRGRPLSA0.92050.8782817
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B14:01ARRGRPLSA0.92050.8782817
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-A31:08RGRPLSAAW0.87680.8891019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B08:09ARRGRPLSA0.83550.8196817
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-A32:13RGRPLSAAW0.63820.96861019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B27:05GRPLSAAWRR0.99930.60661121
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B27:04RRGRPLSAAW0.99880.7086919
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B27:14RRGRPLSAA0.99770.6743918
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B27:14ARRGRPLSA0.99140.7442817
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B73:01ARRGRPLSA0.98590.8911817
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B73:01RRGRPLSAA0.98260.8996918
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B27:03RRGRPLSAAW0.99160.5721919
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B27:03GRPLSAAWRR0.98880.64861121
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-A31:01RGRPLSAAWRR0.98920.76771021
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B57:10RGRPLSAAW0.99780.98421019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B58:06RGRPLSAAW0.99690.98151019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B27:10ARRGRPLSA0.99330.8134817
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B57:04RGRPLSAAW0.98080.84291019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-A32:01RGRPLSAAW0.93280.96231019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B15:24RGRPLSAAW0.91830.96781019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B57:02RGRPLSAAW0.74940.95181019
MTSS1L-DGCR8chr1670719625chr2220077498344HLA-B55:02RPLSAAWRREA0.9380.59311223

Top

Potential FusionNeoAntigen Information of MTSS1L-DGCR8 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MTSS1L-DGCR8_70719625_20077498.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-0820GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1103GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1103RGRPLSAAWRREARP1025
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1104GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1106GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1111GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1125GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1135GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1138GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1141GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1141RGRPLSAAWRREARP1025
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1143GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1144GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1146GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1147GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1150GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1154GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1154RGRPLSAAWRREARP1025
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1155GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1156GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1158GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1159GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1159RGRPLSAAWRREARP1025
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1160GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1163GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1163RGRPLSAAWRREARP1025
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1176GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1176RGRPLSAAWRREARP1025
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1177GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1178GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1183GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1184GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1184RGRPLSAAWRREARP1025
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1185GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1185RGRPLSAAWRREARP1025
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1188GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1189GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1189RGRPLSAAWRREARP1025
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1311GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1318GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1324GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1324RGRPLSAAWRREARP1025
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1342GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1363GRPLSAAWRREARPG1126
MTSS1L-DGCR8chr1670719625chr2220077498344DRB1-1376GRPLSAAWRREARPG1126

Top

Fusion breakpoint peptide structures of MTSS1L-DGCR8

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6637PGARRGRPLSAAWRMTSS1LDGCR8chr1670719625chr2220077498344

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of MTSS1L-DGCR8

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6637PGARRGRPLSAAWR-7.15543-7.26883
HLA-B14:023BVN6637PGARRGRPLSAAWR-4.77435-5.80965
HLA-B52:013W396637PGARRGRPLSAAWR-6.80875-6.92215
HLA-B52:013W396637PGARRGRPLSAAWR-4.20386-5.23916
HLA-A11:014UQ26637PGARRGRPLSAAWR-7.5194-8.5547
HLA-A11:014UQ26637PGARRGRPLSAAWR-6.9601-7.0735
HLA-A24:025HGA6637PGARRGRPLSAAWR-7.52403-7.63743
HLA-A24:025HGA6637PGARRGRPLSAAWR-5.82433-6.85963
HLA-B27:056PYJ6637PGARRGRPLSAAWR-3.28285-4.31815
HLA-B44:053DX86637PGARRGRPLSAAWR-5.91172-6.94702
HLA-B44:053DX86637PGARRGRPLSAAWR-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of MTSS1L-DGCR8

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
MTSS1L-DGCR8chr1670719625chr22200774981019RGRPLSAAWGACATGAAGAAACACGACCCTCCTCTG
MTSS1L-DGCR8chr1670719625chr22200774981021RGRPLSAAWRRGACATGAAGAAACACGACCCTCCTCTGAGTAGC
MTSS1L-DGCR8chr1670719625chr22200774981121GRPLSAAWRRATGAAGAAACACGACCCTCCTCTGAGTAGC
MTSS1L-DGCR8chr1670719625chr22200774981223RPLSAAWRREAAAGAAACACGACCCTCCTCTGAGTAGCATCCCT
MTSS1L-DGCR8chr1670719625chr2220077498817ARRGRPLSAGTCAACGACATGAAGAAACACGACCCT
MTSS1L-DGCR8chr1670719625chr2220077498918RRGRPLSAAAACGACATGAAGAAACACGACCCTCCT
MTSS1L-DGCR8chr1670719625chr2220077498919RRGRPLSAAWAACGACATGAAGAAACACGACCCTCCTCTG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
MTSS1L-DGCR8chr1670719625chr22200774981025RGRPLSAAWRREARPGACATGAAGAAACACGACCCTCCTCTGAGTAGCATCCCTTGTCTG
MTSS1L-DGCR8chr1670719625chr22200774981126GRPLSAAWRREARPGATGAAGAAACACGACCCTCCTCTGAGTAGCATCCCTTGTCTGCAT

Top

Information of the samples that have these potential fusion neoantigens of MTSS1L-DGCR8

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
OVMTSS1L-DGCR8chr1670719625ENST00000338779chr2220077498ENST00000351989TCGA-13-1497

Top

Potential target of CAR-T therapy development for MTSS1L-DGCR8

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to MTSS1L-DGCR8

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to MTSS1L-DGCR8

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource